The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

The risk of hepatocellular carcinoma (HCC) development is reduced following viral elimination by interferon therapy in chronic hepatitis C patients. However, the risk in patients treated with interferon-free direct-acting antivirals (DAAs) is unknown. We evaluated chronic hepatitis C patients who ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagaoki, Yuko, Imamura, Michio, Aikata, Hiroshi, Daijo, Kana, Teraoka, Yuji, Honda, Fumi, Nakamura, Yuki, Hatooka, Masahiro, Morio, Reona, Morio, Kei, Kan, Hiromi, Fujino, Hatsue, Kobayashi, Tomoki, Masaki, Keiichi, Ono, Atsushi, Nakahara, Takashi, Kawaoka, Tomokazu, Tsuge, Masataka, Hiramatsu, Akira, Kawakami, Yoshiiku, Hayes, C. Nelson, Miki, Daiki, Ochi, Hidenori, Chayama, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552231/
https://www.ncbi.nlm.nih.gov/pubmed/28797106
http://dx.doi.org/10.1371/journal.pone.0182710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552231/
https://www.ncbi.nlm.nih.gov/pubmed/28797106
http://dx.doi.org/10.1371/journal.pone.0182710

Ejemplares similares